RESEARCHER PROFILE

Patrícia Ashton‐Prolla

← Back to Universidade Federal do Rio Grande do Sul

P

Universidade Federal do Rio Grande do Sul

BRCA gene mutations in cancerGenetic factors in colorectal cancerCancer-related Molecular PathwaysGenomics and Rare DiseasesBreast Lesions and Carcinomas

Patrícia Ashton‐Prolla works in BRCA gene mutations in cancer, Genetic factors in colorectal cancer, Cancer-related Molecular Pathways, Genomics and Rare Diseases, Breast Lesions and Carcinomas. Recorded institutional associations include Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre.

447Publications
5,283Citations
41H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families

    2006 · 217 citations
  2. Geographic and age variations in mutational processes in colorectal cancer

    2025 · 170 citations
  3. Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect

    2009 · 153 citations
  4. TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review

    2017 · 153 citations
  5. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil

    2008 · 132 citations
  6. Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes.

    2000 · 115 citations
  7. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome

    2009 · 106 citations
  8. Thalidomide, a current teratogen in South America

    1996 · 105 citations
  9. Genomic rearrangements in BRCA1 and BRCA2: a literature review

    2009 · 102 citations
  10. Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

    2017 · 91 citations
  11. The germline mutational landscape of BRCA1 and BRCA2 in Brazil

    2018 · 90 citations
  12. An alternative protocol for DNA extraction from formalin fixed and paraffin wax embedded tissue

    2005 · 85 citations
  13. Geographic variation of mutagenic exposures in kidney cancer genomes

    2024 · 84 citations
  14. Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care

    2009 · 80 citations
  15. TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li–Fraumeni syndrome: impact on age at first diagnosis

    2009 · 78 citations
  16. Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?

    2009 · 77 citations
  17. Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil

    2014 · 75 citations
  18. Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study

    1999 · 74 citations
  19. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma

    2015 · 71 citations
  20. PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines

    2014 · 69 citations
  21. Impact of β1-Adrenergic Receptor Polymorphisms on Susceptibility to Heart Failure, Arrhythmogenesis, Prognosis, and Response to Beta-Blocker Therapy

    2008 · 67 citations
  22. TP53 mutation p.R337H in gastric cancer tissues of a 12-year-old male child - evidence for chimerism involving a common mutant founder haplotype: case report

    2011 · 65 citations
  23. Germline EGFR Mutations and Familial Lung Cancer

    2023 · 60 citations
  24. BDNF/TrkB Content and Interaction with Gastrin-Releasing Peptide Receptor Blockade in Colorectal Cancer

    2010 · 58 citations
  25. XAF1 as a modifier of p53 function and cancer susceptibility

    2020 · 57 citations

← Return to the university profile